Sus scrofa (pig): 100153927
Help
Entry
100153927 CDS
T01009
Symbol
MAPK1
Name
(RefSeq) mitogen-activated protein kinase 1
KO
K04371
mitogen-activated protein kinase 1/3 [EC:
2.7.11.24
]
Organism
ssc
Sus scrofa (pig)
Pathway
ssc01521
EGFR tyrosine kinase inhibitor resistance
ssc01522
Endocrine resistance
ssc01524
Platinum drug resistance
ssc04010
MAPK signaling pathway
ssc04012
ErbB signaling pathway
ssc04014
Ras signaling pathway
ssc04015
Rap1 signaling pathway
ssc04022
cGMP-PKG signaling pathway
ssc04024
cAMP signaling pathway
ssc04062
Chemokine signaling pathway
ssc04066
HIF-1 signaling pathway
ssc04068
FoxO signaling pathway
ssc04071
Sphingolipid signaling pathway
ssc04072
Phospholipase D signaling pathway
ssc04114
Oocyte meiosis
ssc04140
Autophagy - animal
ssc04148
Efferocytosis
ssc04150
mTOR signaling pathway
ssc04151
PI3K-Akt signaling pathway
ssc04210
Apoptosis
ssc04218
Cellular senescence
ssc04261
Adrenergic signaling in cardiomyocytes
ssc04270
Vascular smooth muscle contraction
ssc04350
TGF-beta signaling pathway
ssc04360
Axon guidance
ssc04370
VEGF signaling pathway
ssc04371
Apelin signaling pathway
ssc04380
Osteoclast differentiation
ssc04510
Focal adhesion
ssc04520
Adherens junction
ssc04540
Gap junction
ssc04550
Signaling pathways regulating pluripotency of stem cells
ssc04611
Platelet activation
ssc04613
Neutrophil extracellular trap formation
ssc04620
Toll-like receptor signaling pathway
ssc04621
NOD-like receptor signaling pathway
ssc04625
C-type lectin receptor signaling pathway
ssc04650
Natural killer cell mediated cytotoxicity
ssc04657
IL-17 signaling pathway
ssc04658
Th1 and Th2 cell differentiation
ssc04659
Th17 cell differentiation
ssc04660
T cell receptor signaling pathway
ssc04662
B cell receptor signaling pathway
ssc04664
Fc epsilon RI signaling pathway
ssc04666
Fc gamma R-mediated phagocytosis
ssc04668
TNF signaling pathway
ssc04713
Circadian entrainment
ssc04720
Long-term potentiation
ssc04722
Neurotrophin signaling pathway
ssc04723
Retrograde endocannabinoid signaling
ssc04724
Glutamatergic synapse
ssc04725
Cholinergic synapse
ssc04726
Serotonergic synapse
ssc04730
Long-term depression
ssc04810
Regulation of actin cytoskeleton
ssc04910
Insulin signaling pathway
ssc04912
GnRH signaling pathway
ssc04914
Progesterone-mediated oocyte maturation
ssc04915
Estrogen signaling pathway
ssc04916
Melanogenesis
ssc04917
Prolactin signaling pathway
ssc04919
Thyroid hormone signaling pathway
ssc04921
Oxytocin signaling pathway
ssc04926
Relaxin signaling pathway
ssc04928
Parathyroid hormone synthesis, secretion and action
ssc04929
GnRH secretion
ssc04930
Type II diabetes mellitus
ssc04933
AGE-RAGE signaling pathway in diabetic complications
ssc04934
Cushing syndrome
ssc04935
Growth hormone synthesis, secretion and action
ssc04960
Aldosterone-regulated sodium reabsorption
ssc05010
Alzheimer disease
ssc05020
Prion disease
ssc05022
Pathways of neurodegeneration - multiple diseases
ssc05034
Alcoholism
ssc05132
Salmonella infection
ssc05133
Pertussis
ssc05135
Yersinia infection
ssc05140
Leishmaniasis
ssc05142
Chagas disease
ssc05145
Toxoplasmosis
ssc05152
Tuberculosis
ssc05160
Hepatitis C
ssc05161
Hepatitis B
ssc05163
Human cytomegalovirus infection
ssc05164
Influenza A
ssc05165
Human papillomavirus infection
ssc05166
Human T-cell leukemia virus 1 infection
ssc05167
Kaposi sarcoma-associated herpesvirus infection
ssc05170
Human immunodeficiency virus 1 infection
ssc05171
Coronavirus disease - COVID-19
ssc05200
Pathways in cancer
ssc05203
Viral carcinogenesis
ssc05205
Proteoglycans in cancer
ssc05206
MicroRNAs in cancer
ssc05207
Chemical carcinogenesis - receptor activation
ssc05208
Chemical carcinogenesis - reactive oxygen species
ssc05210
Colorectal cancer
ssc05211
Renal cell carcinoma
ssc05212
Pancreatic cancer
ssc05213
Endometrial cancer
ssc05214
Glioma
ssc05215
Prostate cancer
ssc05216
Thyroid cancer
ssc05218
Melanoma
ssc05219
Bladder cancer
ssc05220
Chronic myeloid leukemia
ssc05221
Acute myeloid leukemia
ssc05223
Non-small cell lung cancer
ssc05224
Breast cancer
ssc05225
Hepatocellular carcinoma
ssc05226
Gastric cancer
ssc05230
Central carbon metabolism in cancer
ssc05231
Choline metabolism in cancer
ssc05235
PD-L1 expression and PD-1 checkpoint pathway in cancer
ssc05417
Lipid and atherosclerosis
Brite
KEGG Orthology (KO) [BR:
ssc00001
]
09130 Environmental Information Processing
09132 Signal transduction
04010 MAPK signaling pathway
100153927 (MAPK1)
04012 ErbB signaling pathway
100153927 (MAPK1)
04014 Ras signaling pathway
100153927 (MAPK1)
04015 Rap1 signaling pathway
100153927 (MAPK1)
04350 TGF-beta signaling pathway
100153927 (MAPK1)
04370 VEGF signaling pathway
100153927 (MAPK1)
04371 Apelin signaling pathway
100153927 (MAPK1)
04668 TNF signaling pathway
100153927 (MAPK1)
04066 HIF-1 signaling pathway
100153927 (MAPK1)
04068 FoxO signaling pathway
100153927 (MAPK1)
04072 Phospholipase D signaling pathway
100153927 (MAPK1)
04071 Sphingolipid signaling pathway
100153927 (MAPK1)
04024 cAMP signaling pathway
100153927 (MAPK1)
04022 cGMP-PKG signaling pathway
100153927 (MAPK1)
04151 PI3K-Akt signaling pathway
100153927 (MAPK1)
04150 mTOR signaling pathway
100153927 (MAPK1)
09140 Cellular Processes
09141 Transport and catabolism
04140 Autophagy - animal
100153927 (MAPK1)
04148 Efferocytosis
100153927 (MAPK1)
09143 Cell growth and death
04114 Oocyte meiosis
100153927 (MAPK1)
04210 Apoptosis
100153927 (MAPK1)
04218 Cellular senescence
100153927 (MAPK1)
09144 Cellular community - eukaryotes
04510 Focal adhesion
100153927 (MAPK1)
04520 Adherens junction
100153927 (MAPK1)
04540 Gap junction
100153927 (MAPK1)
04550 Signaling pathways regulating pluripotency of stem cells
100153927 (MAPK1)
09142 Cell motility
04810 Regulation of actin cytoskeleton
100153927 (MAPK1)
09150 Organismal Systems
09151 Immune system
04611 Platelet activation
100153927 (MAPK1)
04613 Neutrophil extracellular trap formation
100153927 (MAPK1)
04620 Toll-like receptor signaling pathway
100153927 (MAPK1)
04621 NOD-like receptor signaling pathway
100153927 (MAPK1)
04625 C-type lectin receptor signaling pathway
100153927 (MAPK1)
04650 Natural killer cell mediated cytotoxicity
100153927 (MAPK1)
04660 T cell receptor signaling pathway
100153927 (MAPK1)
04658 Th1 and Th2 cell differentiation
100153927 (MAPK1)
04659 Th17 cell differentiation
100153927 (MAPK1)
04657 IL-17 signaling pathway
100153927 (MAPK1)
04662 B cell receptor signaling pathway
100153927 (MAPK1)
04664 Fc epsilon RI signaling pathway
100153927 (MAPK1)
04666 Fc gamma R-mediated phagocytosis
100153927 (MAPK1)
04062 Chemokine signaling pathway
100153927 (MAPK1)
09152 Endocrine system
04910 Insulin signaling pathway
100153927 (MAPK1)
04929 GnRH secretion
100153927 (MAPK1)
04912 GnRH signaling pathway
100153927 (MAPK1)
04915 Estrogen signaling pathway
100153927 (MAPK1)
04914 Progesterone-mediated oocyte maturation
100153927 (MAPK1)
04917 Prolactin signaling pathway
100153927 (MAPK1)
04921 Oxytocin signaling pathway
100153927 (MAPK1)
04926 Relaxin signaling pathway
100153927 (MAPK1)
04935 Growth hormone synthesis, secretion and action
100153927 (MAPK1)
04919 Thyroid hormone signaling pathway
100153927 (MAPK1)
04928 Parathyroid hormone synthesis, secretion and action
100153927 (MAPK1)
04916 Melanogenesis
100153927 (MAPK1)
09153 Circulatory system
04261 Adrenergic signaling in cardiomyocytes
100153927 (MAPK1)
04270 Vascular smooth muscle contraction
100153927 (MAPK1)
09155 Excretory system
04960 Aldosterone-regulated sodium reabsorption
100153927 (MAPK1)
09156 Nervous system
04724 Glutamatergic synapse
100153927 (MAPK1)
04725 Cholinergic synapse
100153927 (MAPK1)
04726 Serotonergic synapse
100153927 (MAPK1)
04720 Long-term potentiation
100153927 (MAPK1)
04730 Long-term depression
100153927 (MAPK1)
04723 Retrograde endocannabinoid signaling
100153927 (MAPK1)
04722 Neurotrophin signaling pathway
100153927 (MAPK1)
09158 Development and regeneration
04360 Axon guidance
100153927 (MAPK1)
04380 Osteoclast differentiation
100153927 (MAPK1)
09159 Environmental adaptation
04713 Circadian entrainment
100153927 (MAPK1)
09160 Human Diseases
09161 Cancer: overview
05200 Pathways in cancer
100153927 (MAPK1)
05206 MicroRNAs in cancer
100153927 (MAPK1)
05205 Proteoglycans in cancer
100153927 (MAPK1)
05207 Chemical carcinogenesis - receptor activation
100153927 (MAPK1)
05208 Chemical carcinogenesis - reactive oxygen species
100153927 (MAPK1)
05203 Viral carcinogenesis
100153927 (MAPK1)
05230 Central carbon metabolism in cancer
100153927 (MAPK1)
05231 Choline metabolism in cancer
100153927 (MAPK1)
05235 PD-L1 expression and PD-1 checkpoint pathway in cancer
100153927 (MAPK1)
09162 Cancer: specific types
05210 Colorectal cancer
100153927 (MAPK1)
05212 Pancreatic cancer
100153927 (MAPK1)
05225 Hepatocellular carcinoma
100153927 (MAPK1)
05226 Gastric cancer
100153927 (MAPK1)
05214 Glioma
100153927 (MAPK1)
05216 Thyroid cancer
100153927 (MAPK1)
05221 Acute myeloid leukemia
100153927 (MAPK1)
05220 Chronic myeloid leukemia
100153927 (MAPK1)
05218 Melanoma
100153927 (MAPK1)
05211 Renal cell carcinoma
100153927 (MAPK1)
05219 Bladder cancer
100153927 (MAPK1)
05215 Prostate cancer
100153927 (MAPK1)
05213 Endometrial cancer
100153927 (MAPK1)
05224 Breast cancer
100153927 (MAPK1)
05223 Non-small cell lung cancer
100153927 (MAPK1)
09172 Infectious disease: viral
05166 Human T-cell leukemia virus 1 infection
100153927 (MAPK1)
05170 Human immunodeficiency virus 1 infection
100153927 (MAPK1)
05161 Hepatitis B
100153927 (MAPK1)
05160 Hepatitis C
100153927 (MAPK1)
05171 Coronavirus disease - COVID-19
100153927 (MAPK1)
05164 Influenza A
100153927 (MAPK1)
05163 Human cytomegalovirus infection
100153927 (MAPK1)
05167 Kaposi sarcoma-associated herpesvirus infection
100153927 (MAPK1)
05165 Human papillomavirus infection
100153927 (MAPK1)
09171 Infectious disease: bacterial
05132 Salmonella infection
100153927 (MAPK1)
05135 Yersinia infection
100153927 (MAPK1)
05133 Pertussis
100153927 (MAPK1)
05152 Tuberculosis
100153927 (MAPK1)
09174 Infectious disease: parasitic
05145 Toxoplasmosis
100153927 (MAPK1)
05140 Leishmaniasis
100153927 (MAPK1)
05142 Chagas disease
100153927 (MAPK1)
09164 Neurodegenerative disease
05010 Alzheimer disease
100153927 (MAPK1)
05020 Prion disease
100153927 (MAPK1)
05022 Pathways of neurodegeneration - multiple diseases
100153927 (MAPK1)
09165 Substance dependence
05034 Alcoholism
100153927 (MAPK1)
09166 Cardiovascular disease
05417 Lipid and atherosclerosis
100153927 (MAPK1)
09167 Endocrine and metabolic disease
04930 Type II diabetes mellitus
100153927 (MAPK1)
04933 AGE-RAGE signaling pathway in diabetic complications
100153927 (MAPK1)
04934 Cushing syndrome
100153927 (MAPK1)
09176 Drug resistance: antineoplastic
01521 EGFR tyrosine kinase inhibitor resistance
100153927 (MAPK1)
01524 Platinum drug resistance
100153927 (MAPK1)
01522 Endocrine resistance
100153927 (MAPK1)
09180 Brite Hierarchies
09181 Protein families: metabolism
01001 Protein kinases [BR:
ssc01001
]
100153927 (MAPK1)
09182 Protein families: genetic information processing
03036 Chromosome and associated proteins [BR:
ssc03036
]
100153927 (MAPK1)
09183 Protein families: signaling and cellular processes
04147 Exosome [BR:
ssc04147
]
100153927 (MAPK1)
Enzymes [BR:
ssc01000
]
2. Transferases
2.7 Transferring phosphorus-containing groups
2.7.11 Protein-serine/threonine kinases
2.7.11.24 mitogen-activated protein kinase
100153927 (MAPK1)
Protein kinases [BR:
ssc01001
]
Serine/threonine kinases: CMGC group
MAPK family [OT]
100153927 (MAPK1)
Chromosome and associated proteins [BR:
ssc03036
]
Eukaryotic type
Centromeric chromatin formation proteins
SAC (spindle assembly checkpoint) factors
Protein kinases
100153927 (MAPK1)
Exosome [BR:
ssc04147
]
Exosomal proteins
Exosomal proteins of haemopoietic cells (B-cell, T-cell, DC-cell, reticulocyte, and mast cell)
100153927 (MAPK1)
BRITE hierarchy
SSDB
Ortholog
Paralog
Gene cluster
GFIT
Motif
Pfam:
Pkinase
PK_Tyr_Ser-Thr
ABC1
APH
Haspin_kinase
Choline_kinase
FTA2
Kdo
Motif
Other DBs
NCBI-GeneID:
100153927
NCBI-ProteinID:
NP_001185851
Ensembl:
ENSSSCG00000010081
Vega:
OTTSUSG00000001605
UniProt:
E3UV40
LinkDB
All DBs
Position
14:50083079..50165528
Genome browser
AA seq
359 aa
AA seq
DB search
MAAAAAGAGPEMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEH
QTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHL
SNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHT
GFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILADMLSNRPIFPGKHYLDQLNHIL
GILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKR
IEVEQALAHPYLEQYYDPSDEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQPGYRS
NT seq
1080 nt
NT seq
+upstream
nt +downstream
nt
atggcggcggcggcggcgggcgcgggccccgagatggtccgcgggcaggtgttcgacgtg
gggccgcgctacaccaacctctcctacatcggcgagggcgcctacggcatggtgtgctct
gcttatgataatgtcaacaaagttcgagtagctatcaagaaaatcagtccatttgagcat
cagacctactgccagagaaccctgagggagataaaaatcttactgcgctttagacacgag
aacatcattggaatcaatgatatcattcgagcaccaaccatcgagcagatgaaagatgta
tacatagtacaggacctcatggaaacagatctctacaagctcttgaagacgcagcacctc
agcaacgaccatatctgctattttctttaccagatcctcagagggttaaaatatatccat
tcagctaacgtactgcaccgtgacctcaaaccttccaacctgctgctcaacaccacctgc
gatctcaagatctgtgactttgggttggcccgtgttgcagatccagaccatgatcacaca
gggttcctgacggagtatgtcgccacacgttggtacagggctccagaaattatgttaaat
tccaagggctacaccaagtccatcgacatctggtctgtcggctgcatcttggcagatatg
ctctccaacaggcccatcttcccggggaagcattatctcgaccagctgaaccacattctg
ggtattcttggatccccatcacaggaagacctgaattgtataataaatttaaaagctaga
aactatttgctttctcttccacacaaaaataaggtgccatggaacaggctgttcccaaat
gctgactccaaagctctggatttactggacaaaatgttgacattcaaccctcacaagagg
attgaagtagagcaggctcttgcccacccatacctggagcagtattatgacccaagtgat
gagcccatcgctgaagcaccattcaagtttgacatggaattggatgacttgcccaaggaa
aagctcaaagagctcatttttgaagagaccgctcgattccagccaggatacagatcttaa
DBGET
integrated database retrieval system